» Articles » PMID: 35888751

Quercetin Decreases Corneal Haze In Vivo and Influences Gene Expression of TGF-Beta Mediators In Vitro

Overview
Journal Metabolites
Publisher MDPI
Date 2022 Jul 27
PMID 35888751
Authors
Affiliations
Soon will be listed here.
Abstract

We have previously reported the flavonoid, quercetin, as a metabolic regulator and inhibitor of myofibroblast differentiation in vitro. Our current study evaluated the effects of topical application of quercetin on corneal scar development using two different animal models followed by RNA analysis in vitro. Wild-type C57BL/6J mice were anesthetized and the corneal epithelium and stroma were manually debrided, followed by quercetin (0.5, 1, 5, or 50 mM) or vehicle application. Corneal scarring was assessed for 3 weeks by slit lamp imaging and clinically scored. In a separate animal study, six New Zealand White rabbits underwent lamellar keratectomy surgery, followed by treatment with 5 mM quercetin or vehicle twice daily for three days. Stromal backscattering was assessed at week 3 by in vivo confocal microscopy. In mice, a single dose of 5 mM quercetin reduced corneal scar formation. In rabbits, stromal backscattering was substantially lower in two out of three animals in the quercetin-treated group. In vitro studies of human corneal fibroblasts showed that quercetin modulated select factors of the transforming growth factor-β (TGF-β) signaling pathway. These results provide evidence that quercetin may inhibit corneal scarring. Further studies in a larger cohort are required to validate the efficacy and safety of quercetin for clinical applications.

Citing Articles

The effects of Quercetin on wound healing in the human umbilical vein endothelial cells.

Kartal B, Alimogullari E, Elci P, Fatsa T, Oren S Cell Tissue Bank. 2024; 25(3):851-860.

PMID: 38944663 DOI: 10.1007/s10561-024-10144-1.


Dexamethasone sodium phosphate loaded nanoparticles for prevention of nitrogen mustard induced corneal injury.

Poudel S, Kaffash E, Zhao L, Pangeni R, Chow W, Xu Q Exp Eye Res. 2024; 243:109902.

PMID: 38641196 PMC: 11184523. DOI: 10.1016/j.exer.2024.109902.


Quercetin and Related Analogs as Therapeutics to Promote Tissue Repair.

McKay T, Emmitte K, German C, Karamichos D Bioengineering (Basel). 2023; 10(10).

PMID: 37892857 PMC: 10604618. DOI: 10.3390/bioengineering10101127.


Flavonoids as Potential Wound-Healing Molecules: Emphasis on Pathways Perspective.

Zulkefli N, Che Zahari C, Sayuti N, Kamarudin A, Saad N, Hamezah H Int J Mol Sci. 2023; 24(5).

PMID: 36902038 PMC: 10003005. DOI: 10.3390/ijms24054607.


Role of Oxidative Stress in Ocular Diseases: A Balancing Act.

Shu D, Chaudhary S, Cho K, Lennikov A, Miller W, Thorn D Metabolites. 2023; 13(2).

PMID: 36837806 PMC: 9960073. DOI: 10.3390/metabo13020187.


References
1.
Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

2.
Ramirez T, Li Y, Yin S, Xu M, Feng D, Zhou Z . Aging aggravates alcoholic liver injury and fibrosis in mice by downregulating sirtuin 1 expression. J Hepatol. 2016; 66(3):601-609. PMC: 5316497. DOI: 10.1016/j.jhep.2016.11.004. View

3.
Harwood M, Danielewska-Nikiel B, Borzelleca J, Flamm G, Williams G, Lines T . A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 2007; 45(11):2179-205. DOI: 10.1016/j.fct.2007.05.015. View

4.
Netto M, Mohan R, Sinha S, Sharma A, Dupps W, Wilson S . Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp Eye Res. 2005; 82(5):788-97. PMC: 2693937. DOI: 10.1016/j.exer.2005.09.021. View

5.
Gryglewski R, Korbut R, Robak J, Swies J . On the mechanism of antithrombotic action of flavonoids. Biochem Pharmacol. 1987; 36(3):317-22. DOI: 10.1016/0006-2952(87)90288-7. View